Pharmacy

Cost control rationale for pharmacare does not stand up to scrutiny: Canadian Health Policy Institute

Retrieved on: 
Thursday, March 14, 2024
Annual report, Physician, Pan-Canadian Pharmaceutical Alliance, Patient, Pharmacy, Hospital, Public Health Agency, Policy, Overalls, PMPRB, Agency, Parity, CIHI, Pharmacare, NDP, Government

TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- The latest edition of an annual study from the Canadian Health Policy Institute concludes that the cost control rationale for national pharmacare is not supported by the facts.

Key Points: 
  • TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- The latest edition of an annual study from the Canadian Health Policy Institute concludes that the cost control rationale for national pharmacare is not supported by the facts.
  • It is a symbolic step toward a national pharmacare program that will replace existing public and private drug plans.
  • Pharmacare advocates are betting a single payer can demand deeper discounts without jeopardizing the availability of new medicines in Canada.
  • Excessive cost controls for patented medicines are counterproductive.”
    “It appears unlikely that the current government will rethink its pharmacare policy.

Wolf Greenfield Law Firm Elects Robert Walat as President and Managing Partner

Retrieved on: 
Wednesday, March 13, 2024
Pharmacy, Culture, Strategic planning, Partner (business rank), Pleasure, P.C, Senior counsel

BOSTON and NEW YORK and WASHINGTON, March 13, 2024 (GLOBE NEWSWIRE) -- Wolf, Greenfield & Sacks, P.C., one of the 10 largest law firms in the country devoted exclusively to intellectual property law, is pleased to announce that Robert Walat has been elected President and Managing Partner.

Key Points: 
  • BOSTON and NEW YORK and WASHINGTON, March 13, 2024 (GLOBE NEWSWIRE) -- Wolf, Greenfield & Sacks, P.C., one of the 10 largest law firms in the country devoted exclusively to intellectual property law, is pleased to announce that Robert Walat has been elected President and Managing Partner.
  • “Wolf Greenfield has always been more than just a place of work for me.
  • I’ve also been fortunate enough to work alongside exceptional clients to develop and execute on their intellectual property strategies,” said Walat.
  • Prior to joining Wolf Greenfield, Walat had industry experience as a material scientist.

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Retrieved on: 
Wednesday, March 13, 2024
Research, Hypersensitivity, Glucose, Deafness, Congestion, Ascites, Furosemide, Cerebral edema, Growth, Edema, Kidney, Ototoxicity, Diuresis, Tinnitus, Bruise, New Drug Application, Patient, Coma, Oliguria, History, NYHA, NDA, Benign prostatic hyperplasia, IDN, Blood volume, Embolism, Insurance, Thrombosis, Trial of the century, Heart failure, Investment, CO2, Urine, Dehydration, Creatinine, Urinary retention, Erythema, Pharmacy, Chronic kidney disease, Organic acid, Patent, Hypoproteinemia, Internationalized domain name, BUN, Huber loss, FDA, Government, GTN, Cirrhosis, Hepatic encephalopathy, Azotemia, Uric acid, Anuria, Pharmaceutical industry

BURLINGTON, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced financial results for the fourth quarter and full-year ended December 31, 2023, and provided a business update. 

Key Points: 
  • Product revenues were $6.1 million, and cost of product revenues were $1.8 million for the fourth quarter of 2023.
  • Research and development expenses were $3.3 million for the fourth quarter of 2023, compared to $2.3 million for the fourth quarter of 2022.
  • Selling, general and administrative expenses were $16.2 million for the fourth quarter of 2023, compared to $7.2 million for the fourth quarter of 2022.
  • scPharmaceuticals reported a net loss of $13.8 million for the fourth quarter of 2023, compared to $9.2 million for the fourth quarter of 2022.

3Daughters Announces Three New Appointments to Board of Directors

Retrieved on: 
Wednesday, March 13, 2024
Quotient, Thakeham, Alnylam Pharmaceuticals, CDMO, Birth, Labs, GSK plc, Pharmacy, University, Novartis, Dana–Farber Cancer Institute, IUD, University College London, Embryology, IND, MBA, Woman, Doctor of Philosophy, Intrauterine device, Therapy, Drug development, Allergan, Amersham plc, Takeda Oncology, Chief Justice of Hungary, Pharmacia, Birth control

Miles, Ph.D., and Sarah J. Stevens, Ph.D., to serve on the Company’s Board of Directors.

Key Points: 
  • Miles, Ph.D., and Sarah J. Stevens, Ph.D., to serve on the Company’s Board of Directors.
  • An IND for 3D-001 will be filed this year followed by a Phase 1 clinical trial.
  • Mary Beth Cicero, CEO of 3Daughters, expressed her enthusiasm about the new additions to the board: "We are incredibly excited to have the collective strengths of Michele, Sarah, and Vin on our Board of Directors.
  • With this first product, 3Daughters expects to disrupt the IUD market and establish a position as a major innovator in women's healthcare.

Registration Opens for the National Association of Specialty Pharmacy 2024 Annual Meeting & Expo

Retrieved on: 
Tuesday, March 12, 2024
Convention center, Pharmacist, Annual, Organ transplantation, Rheumatoid arthritis, CE, Woman, Multiple sclerosis, Haemophilia, Pharmacy, Patient, Cancer, Abstract, Love, Specialty pharmacy, National Association, CSP, Cell, Data management, Nursing, Education, NASP, Consultant, Cystic fibrosis, Accreditation, Hospital

Washington, DC, March 12, 2024 (GLOBE NEWSWIRE) -- Today, the National Association of Specialty Pharmacy (NASP), the only industry association in the U.S. whose membership includes all specialty pharmacy stakeholders, opened registration for the NASP 2024 Annual Meeting & Expo, to be held October 6 - 9, 2024, at the Gaylord Opryland Resort & Convention Center in Nashville, TN.

Key Points: 
  • Washington, DC, March 12, 2024 (GLOBE NEWSWIRE) -- Today, the National Association of Specialty Pharmacy (NASP), the only industry association in the U.S. whose membership includes all specialty pharmacy stakeholders, opened registration for the NASP 2024 Annual Meeting & Expo, to be held October 6 - 9, 2024, at the Gaylord Opryland Resort & Convention Center in Nashville, TN.
  • “The NASP 2024 Annual Meeting & Expo offers everything that attendees have come to love and expect, including top-of-class educational content and networking events.
  • Workshops include Accreditation, Cell & Gene Therapy, Certified Specialty Pharmacist (CSP) Exam Prep Course, Hospital/Health System Specialty Pharmacy, Specialty Pharmacy Law, and Technology.
  • The Annual Meeting & Expo also features a showcase for specialty pharmacy clinical research with its abstract and poster program.

Solera and Aon Collaborate to Offer Employers Curated Network of Digital Health Solutions and Analytics for Clinical Outcomes and Cost Savings

Retrieved on: 
Tuesday, March 12, 2024
AON, HALO, Algorithm, Noise, Pharmacy, Solera, Nursing

This joint effort helps more employers deliver personalized employee health experiences and optimize health outcomes for the most common chronic conditions.

Key Points: 
  • This joint effort helps more employers deliver personalized employee health experiences and optimize health outcomes for the most common chronic conditions.
  • By integrating the Solera HALO™ omni-condition management platform with Aon’s Health Risk Navigator predictive analytics tool, employers may harness innovations in digital health by providing access to Solera’s carefully curated network of clinically validated resources - with the ability to identify and engage high-risk employees.
  • Aon will then combine Solera’s solution engagement, utilization and clinical data with employers’ medical and pharmacy data to measure health outcomes and employers’ return on investment for health services that their employees use.
  • “We are thrilled to work with Aon to help deliver best-in-class condition management to US employers,” said Mary Langowski, CEO at Solera.

RLS Radiopharmacies Partners with Eckert & Ziegler to Expand Production of Gallium-68-Based Radiopharmaceuticals

Retrieved on: 
Thursday, April 4, 2024
Oncology, Medical Devices, Health, Radiology, Pharmaceutical, Biotechnology, Gallium, Diagnosis, Radionuclide, Glomus tumor, Prostate cancer, USP, Half-life, Actinium-225, Partnership, Patient, Pharmacy, RLS, PET, Splenic infarction, Cancer, SDAX, Radiopharmaceutical, Investment, Cyclotron, ISO, Positron emission tomography, DSM-IV codes, Gelastic seizure, Medical imaging

Under the partnership, all 31 of RLS’s radiopharmacies will be equipped with Eckert & Ziegler’s advanced GalliaPharm® generators, which the radiopharmacy network will utilize to produce high-quality, life-enhancing Gallium-68-based (Ga-68) radiopharmaceuticals.

Key Points: 
  • Under the partnership, all 31 of RLS’s radiopharmacies will be equipped with Eckert & Ziegler’s advanced GalliaPharm® generators, which the radiopharmacy network will utilize to produce high-quality, life-enhancing Gallium-68-based (Ga-68) radiopharmaceuticals.
  • “A powerful diagnostic isotope, Gallium has an extremely short half-life, necessitating the need for Ga-68-based radiopharmaceuticals to be produced within minutes of patient dosing.
  • This signifies a major leap forward in our commitment to advancing healthcare and improving patient outcomes through cutting-edge radiopharmaceuticals."
  • To date, RLS has installed Eckert & Ziegler’s GalliaPharm® generators within most of its locations and anticipates the remaining radiopharmacies will be operational by the end of June.

Sam’s Club Plus Membership Benefits (2024) Reviewed by Compare Before Buying

Retrieved on: 
Thursday, April 4, 2024
Other Retail, General Health, Health, Consumer Electronics, Technology, Consumer, Other Consumer, Retail, Friends, Sam's Club, Environment, Electronics, Tire, Plus, Club, Pharmacy, Sam, Family

As the value of membership shopping is ever-increasing, Compare Before Buying has released an in-depth analysis of Sam's Club Plus Membership benefits , offering consumers a detailed look at the advantages and enhancements that come with this premium service.

Key Points: 
  • As the value of membership shopping is ever-increasing, Compare Before Buying has released an in-depth analysis of Sam's Club Plus Membership benefits , offering consumers a detailed look at the advantages and enhancements that come with this premium service.
  • This review aims to guide shoppers through the myriad of perks, savings, and conveniences that Sam’s Club Plus membership offers, empowering consumers to make informed decisions about membership shopping options.
  • While the basic membership grants access to low prices and exclusive offers, the Plus membership tier elevates the shopping experience with a suite of additional benefits.
  • The Plus Membership reflects the retailer's dedication to offering high-quality service and a range of benefits.

Cambridge Savings Bank Supports the Expansion of Fair Haven Community Health Care with Loans Totaling Over $26 Million

Retrieved on: 
Thursday, April 4, 2024
Professional Services, Health, Hospitals, Other Health, Finance, Banking, Community, Savings bank, Dental care, Organization, Patient, History, CSB, CHC, Senior, Treasury management, Pediatrics, Pharmacy, Yale University, Corporation

Cambridge Savings Bank (CSB), a full-service mutual bank with a customer-first approach and over $6 billion in assets, today announced that its Corporate Banking team has provided Fair Haven Community Health Care (Fair Haven CHC) with a combined $26.1 million in loans to support its expansion.

Key Points: 
  • Cambridge Savings Bank (CSB), a full-service mutual bank with a customer-first approach and over $6 billion in assets, today announced that its Corporate Banking team has provided Fair Haven Community Health Care (Fair Haven CHC) with a combined $26.1 million in loans to support its expansion.
  • Based in New Haven, Connecticut, Fair Haven CHC provides low-income families with accessible, high-quality medical and dental care, regardless of their ability to pay.
  • With 20 locations including 12 satellite centers at local greater New Haven schools, Fair Haven CHC currently serves over 34,000 patients across a wide range of primary and specialty care services.
  • “Cambridge Savings Bank's community-focused approach and clear understanding of our mission have made the bank an invaluable ally in our expansion efforts.

FPT Software Achieves Double Wins at Healthcare Asia Medtech Awards 2024

Retrieved on: 
Friday, April 5, 2024
Data Management, Health, Technology, Health Technology, Software, Networks, FPT Software, HITRUST, Pharmacy, HL7, AWS, HIPAA, ISO 13485, Multimedia, ISO, DICOM, FPT

Global IT firm FPT Software recently won two categories in the Healthcare Asia Medtech Awards 2024: the Digital Innovation of the Year - Vietnam and the Initiative Award - Vietnam.

Key Points: 
  • Global IT firm FPT Software recently won two categories in the Healthcare Asia Medtech Awards 2024: the Digital Innovation of the Year - Vietnam and the Initiative Award - Vietnam.
  • This marks the second consecutive year the firm has been honored with these awards, solidifying its position as a world-class service provider in the healthcare industry.
  • View the full release here: https://www.businesswire.com/news/home/20240404598004/en/
    Organized by Healthcare Asia, the premier industry magazine catering to hospital owners, investors, administrators, and policymakers across Asia, the annual Healthcare Asia Medtech Awards are designed to recognize and highlight outstanding medtech companies in the region that consistently surpass expectations by delivering groundbreaking innovations to their customers.
  • FPT Software is among over 250 applications this year from businesses across the Asia Pacific region and stands out as the sole nominee from Vietnam to claim two esteemed awards.